Pharming (PHAR) Selling, General & Administrative (2020 - 2026)
Pharming (PHAR) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 2.17 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 555.10 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -355.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 101.25 Mn |
| 10 | Pharming | 8.69 Bn | 8.64 Bn | 65.80 Mn | -15.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.22 Mn |
| Dec 31, 2025 | -20.00 |
| Sep 30, 2025 | -17.00 |
| Jun 30, 2025 | -42.99 Mn |
| Mar 31, 2025 | -22.49 Mn |
| Dec 31, 2024 | -46.00 |
| Sep 30, 2024 | -15.30 |
| Jun 30, 2024 | -30.71 Mn |
| Mar 31, 2024 | -15.09 Mn |
| Dec 31, 2023 | -55.88 Mn |
| Sep 30, 2023 | -10.89 Mn |
| Jun 30, 2023 | -11.00 |
| Mar 31, 2023 | -9.98 Mn |
| Dec 31, 2022 | -28.50 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Dec 31, 2021 | 21.45 Mn |
| Sep 30, 2021 | -7.43 Mn |
| Dec 31, 2020 | 16.27 Mn |
| Sep 30, 2020 | -5.55 Mn |